Morphoceuticals, Inc.
PrivateLast Round
Seed
Feb 15, 2023
Total Funding Raised
$8M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Morphoceuticals, Inc. is a biotechnology company that develops AI-guided electroceuticals for tissue repair and organ regeneration by targeting the bioelectrome.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Morphoceuticals, Inc. Comparables
Compare Morphoceuticals, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Mogrify | 73% | |
| Turn Biotechnologies | 67% | |
| Altos Labs | 66% | |
Morphoceuticals, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 15, 2023 |
Morphoceuticals, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prime Movers Lab | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 69% MoM, from 1.2K to 2.1K.
- May 14, 2026
Monthly visitors grew 113% MoM, reaching 2.1K.
Morphoceuticals, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Morphoceuticals, Inc.'s valuation, stock price, and market status.